Organogels, hydrogels and bigels as transdermal delivery systems for diltiazem hydrochloride

Asian Journal of Pharmaceutical Sciences

Volumn 8, Issue 1, 2013, Pages 48-57

  Ibrahim, Mahmoud Mokhtar ^a,b   Hafez, Salma A ^a   Mahdy, Mahmoud M ^a  

^a Zagazig University   (Egypt)

^b NAJRAN UNIVERSITY   (Saudi Arabia)

Author keywords

Bigels; Hydrogels; Lecithin; Organogels; Span

Indexed keywords

EID: 84906564523     PISSN: 18180876     EISSN: 2221285X     Source Type: Journal    
DOI: 10.1016/j.ajps.2013.07.006     Document Type: Article

References (41)

1. Barrat, G.M., Therapeutic applications of colloidal drug carriers. Pharm Sci Technol Today 3 (2000), 163–171.
2. O'Connor, S.E., Grosset, A., Janiak, P., The pharmacological basis and pathophysiological significance of the heart rate lowering property of diltiazem. Fundam Clin Pharmacol 13:2 (1999), 145–153.
3. Margret, C., Chandramohan, Debjit, et al. Design and characterisation of sustain release gastro retentive floating tablets of diltiazem hydrochloride. Der Pharmacia Lettre 1:2 (2009), 25–38.
4. Gannu, R., Vishnu, Y.V., Kishan, V., et al. Development of nitrendipin transdermal patches. Curr Drug Deliv 4 (2007), 69–76.
5. Rajesh, K., Pitchaimani, R., Formulation of transdermal drug delivery system. Curr Drug Discov Technolo 3 (2006), 279–285.
6. Eaglstein, W.H., Moist wound healing with occlusive dressings: a clinical focus. Dermatol Surg 27 (2001), 175–181.
7. Murdan, S., Organogels in drug delivery. Expert Opin Drug Del 2 (2005), 489–505.
8. Terech, P., Weiss, R.G., Low molecular mass gelators of organic liquids and the properties of their gels. Chem Rev 97 (1997), 3133–3160.
9. Shchipunov, Y.A., Lecithin organogel: a micellar system with unique properties. Colloids Surf A Physicochem Eng Asp 183-185 (2001), 541–554.
10. Murdan, S., A review of pluronic lecithin organogel as a topical and transdermal drug delivery system. Hosp Pharmacist 12 (2005), 267–270.
11. Almeida, I.F., Fernandes, A.R., Fernandes, L., et al. Moisturizing effect of oleogel/hydrogel mixtures. Pharm Dev Technol 13 (2008), 487–494.
12. Shaikh, I.M., Jadhav, S.L., Jadhav, K.R., et al. Aceclofenac organogels: in vitro and in vivo characterization. Curr Drug Deliv 6 (2009), 1–7.
13. Lognathan, V., Manimaran, S., Jaswanth, A., et al. The effect of polymers and permeation enhancers on release of flubiprofen from gel formulations. Ind J Pharm Sci 63:3 (2001), 200–204.
14. Mahmoud, M.I., Omaima, A.S., Mohamed, A.H., et al. In vitro evaluation of proniosomes as a drug carrier for flurbiprofen. AAPS Pharm Sci Tech 9:3 (2008), 782–790.
15. Ghazy, F.S., Ghareeb, S.A., Mahdy, M.A., et al. Comparative in vitro and in vivo studies of transdermal absorption of certain vasodilators. Alex J Pharm Sci 18:2 (2004), 151–158.
16. Mura, P., Faucci, M.T., Bramanti, G., et al. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci 9 (2000), 365–372.
17. Cangiano, J.L., Rodriguez, S.C., Martinez, M.M., J Pharmacol Exp Ther 208:2 (1979), 310–313.
18. Douglas, J.R., Johnson, E.M., Heist, J.F., et al. J Pharmacol Exp Ther 196 (1976), 35–43.
19. Paget, G.E., Barnes, J.M., Interspecies dosage conversion schem in evaluation of results and quantitative application in different species. Laurence, D.R., Bacharach, A.L., (eds.) Evaluation of drug activities: pharmacometrics, vol. 1, 1964, Academic Press, London, New York, 160–162.
20. Amidon, G.L., Lennernas, H., Shah, V.P., et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12 (1995), 413–420.
21. Burden, D.T., Balber, L.C., Natoff, I.L., A simple method for recording left ventricular pressure and heart rate in cats. J Pharmacol Ther 5 (1979), 99–102.
22. Darne, B., Girerd, X., Safar, M., et al. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 13:4 (1989), 392–400.
23. Trivedi, D.R., Ballabh, A., Dastidar, P., et al. Structure property correlation of a new family of organogelators based on organic salts and their selective gelation of oil from oil/water mixtures. Chemistry 10 (2004), 5311–5322.
24. Effendy, I., Maibach, H.I., Surfactants and experimental irritant contact dermatitis. Contact Dermatitis 33:4 (1995), 217–225.
25. Mazzo, D.J., Obetz, C.L., Shuster, J., Britain, H.G., (eds.) Diltiazem hydrochloride. Analytical profiles of drug substances and excipients, vol. 23, 1994, Academic Press, San Diego, 54–98.
26. Sultana, Y., Mall, S., Maurya, D., et al. Preparation and in vitro characterization of diltiazem hydrochloride loaded alginate microspheres. Pharm Dev Tech 14:3 (2009), 321–331.
27. Worth, A.P., Cronin, M.T.D., The use of pH measurements to predict the potential of chemicals to cause acute dermal and ocular toxicity. Toxicology 169 (2001), 119–131.
28. Ruíz, M.M.A., Gallardo, J.L.V., Benavides, M.M., et al. Rheological behavior of gels and meloxicam release. Int J Pharm 333 (2007), 17–23.
29. Vintiloiu, A., Leroux, J.C., Organogels and their use in drug delivery-A review. J Control Rel 125:3 (2008), 179–192.
30. Yang, Y., Wang, S., Xua, H., et al. Properties of topically applied organogels: rheology and in vitro drug release. Asian J Pharm Sci 3:4 (2008), 175–183.
31. Nokhodchi, A., Khaseh, P., Ghafourian, T., et al. The role of various surfactants and fillersin controlling the release rate of theophylline from HPMC matrices. STP Pharma Sci 9 (1999), 555–560.
32. Pisal, S., Shelke, V., Mahadik, K., et al. Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride. AAPS PharmSciTech 5:4 (2004), 92–100.
33. Yaghmur, A., Campo, L., Aserin, A., et al. Structural characterization of five component food grade oil in water nonionic microemulsions. Phys Chem Chem Phys 6:7 (2004), 1524–1533.
34. Murdan, S., Gregoriadis, G., Florence, A.T., Non-ionic surfactant organogels incorporating niosomes. STP Pharma Sci 6 (1996), 44–48.
35. Cociello, T., Matricardi, P., Marianecci, C., et al. Polysaccharide hydrogels for modified release formulations. J Control Rel 119 (2007), 5–24.
36. Gupta, S., Bicompatible microemulsion systems for drug encapsulation and delivery. Curr Sci 101:2 (2011), 174–188.
37. Phaechamud, T., Variables influencing drug release from layered matrix system comprising hydroxypropyl methylcellulose. AAPS PharmSciTech 9:2 (2008), 668–674.
38. Lehmann, K.A., Zech, D., Transdermal fentanyl clinical pharmacology. J Pain Symptom Manage 7 (1992), S8–S16.
39. Ghosal, K., Chakrabarty, S., Nanda, A., Hydroxypropyl methylcellulose in drug delivery. Der Pharmacia Sinica 2:2 (2011), 152–168.
40. Scartazzini, R., Luisi, P.L., Organogels from lecithins. J Phys Chem 92:3 (1988), 829–833.
41. Willimann, H., Walde, P., Lusi, P.L., et al. Lecithin organogels as matrix for transdermal transport of drugs. J Pharm Sci 81 (1992), 871–874.